台股 » 個股 » 神隆 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

神隆

(1789)
可現股當沖
  • 股價
    28.10
  • 漲跌
    ▲0.25
  • 漲幅
    +0.90%
  • 成交量
    1,007
  • 產業
    上市 生技醫療類股
  • 301人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
神隆 (1789)籌碼相關-富邦-興業 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-興業 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2023/08/11628.6800.0028.5563,0530.20%
2023/08/10228.95429.0429.05-23,039-0.07%
2023/08/08231.0000.0030.9022,9850.07%
2023/08/07031.60231.5532.10-22,970-0.07%
2023/08/0100.001132.2832.70-112,900-0.38%
2023/07/310.832.09232.2531.85-1.22,875-0.04%
2023/07/2600.00231.8331.65-22,839-0.07%
2023/07/2500.001132.7332.80-112,850-0.39%
2023/07/24332.10132.0032.1022,8620.07%
2023/07/21431.9900.0031.5042,8010.14%
2023/07/20431.80831.7031.30-42,686-0.15%
2023/07/19633.62233.9033.3542,3900.17%
2023/07/182634.27334.2733.70232,2131.04%
2023/07/17133.25533.2533.25-41,891-0.21%
2023/07/144629.513829.7230.2581,8060.44%
2023/07/1300.00128.9028.85-11,775-0.06%
2023/07/12128.8500.0028.9511,8200.05%
2023/07/1100.00329.5529.45-31,859-0.16%
2023/07/07128.3000.0028.2011,8000.06%
2023/07/0500.00129.4529.40-11,753-0.06%
2023/07/03329.7500.0029.7531,7030.18%
2023/06/30330.151030.2730.25-71,655-0.42%
2023/06/28428.9000.0029.4041,5380.26%
2023/06/27128.90228.8028.75-11,495-0.07%
2023/06/26229.0000.0028.7521,4810.13%
2023/06/20128.7500.0028.9011,4470.07%
2023/06/1900.00129.0029.00-11,410-0.07%
2023/06/16528.95128.4028.6041,3560.29%
2023/06/1500.00228.1028.05-21,274-0.16%
2023/06/1300.002027.6527.70-201,214-1.65%
2023/06/1200.001027.5826.90-101,177-0.85%
2023/06/0815226.31226.5026.351501,16212.90% 大買/鉅額交易
2023/06/0700.001026.8526.90-101,164-0.86%
2023/06/0500.001526.6026.55-151,182-1.27%
2023/05/30526.0500.0026.0551,2080.41%
2023/05/2627526.0800.0026.002751,21422.63% 大買/鉅額交易
2023/05/251526.3800.0026.30151,2101.24%
2023/05/2300.001026.7826.80-101,210-0.83%
2023/05/1910726.3000.0026.351071,2148.81% 大買/鉅額交易
2023/05/1800.00526.9026.90-51,196-0.42%
2023/05/1700.001026.6026.65-101,182-0.85%
2023/05/15526.0000.0025.9051,1580.43%
2023/05/122226.8000.0026.20221,1701.88%
2023/05/112226.8000.0026.40221,1711.88%
2023/05/08227.7000.0027.5521,1670.17%
2023/05/05128.1000.0028.1511,1640.09%
2023/05/04728.3900.0028.5571,1750.60%
2023/05/0200.00628.8528.65-61,171-0.51%
2023/04/28428.8900.0028.4041,1540.35%
2023/04/2738028.23527.9528.303751,07934.72% 大買/鉅額交易
2023/04/2600.00127.5027.50-11,017-0.10%
2023/04/2500.00427.3827.15-41,011-0.40%
2023/04/2400.001327.0527.05-13999-1.30%
2023/04/211626.7100.0026.65161,0031.59%
2023/04/20227.4800.0026.9521,0180.20%
2023/04/1900.00227.6027.30-21,006-0.20%
2023/04/1800.001027.5727.25-10990-1.01%
2023/04/171027.651527.6527.75-5971-0.51%
2023/04/141,10027.153026.9327.001,070931114.85% 大買/鉅額交易
2023/04/13526.20526.5026.3508840.00%
2023/04/112026.2800.0026.20209192.18%
2023/04/1000.00526.7526.45-5939-0.53%
逸達前列腺癌新藥獲美藥證 神隆同步受惠Anue鉅亨-2021/05/27
〈神隆法說〉上游原物料漲幅過大 部分產品將啟動漲價Anue鉅亨-2021/05/26
〈神隆法說〉常熟廠代客研製新藥下半年放量 營運可望改善Anue鉅亨-2021/05/26
神隆 相關文章